Kerman & Co advises the shareholders of Incisive Health Ltd on its sale to FTSE 250 listed UDG Healthcare PLC
June 21, 2019
“As deal novices, it was absolutely vital that we had legal advisors who we could trust. The Kerman & Co team were brilliant.”
Kerman & Co has advised the shareholders of Incisive Health Ltd (Incisive Health) – Sarah Winstone, Bill Morgan and Mike Birtwistle – on its sale to a subsidiary of FTSE 250 listed UDG Healthcare PLC.
Incisive Health is an award-winning healthcare communications consultancy based in London which specialises in healthcare policy, public affairs and communication services. Across its head office in London and an office in Brussels, the consultancy provides a suite of consultancy and communications services including clinical advocacy, corporate and digital communications, direct payer engagement, public affairs, stakeholder campaigning, strategic and policy development and training programmes. Incisive Health has a diversified client base of predominately pharmaceutical and biotech companies.
Incisive Health was acquired for a total consideration of up to £13.6 million ($17.7 million) which included initial consideration of £8 million ($10.4 million), with an earn out of up to £5.6 million ($7.3 million) payable over the next three years, based on the achievement of specific profit targets.
Commenting on the acquisition, Mike Birtwistle, one of the three founding partners of Incisive Health said: “As deal novices, it was absolutely vital that we had legal advisors who we could trust. The Kerman & Co team were brilliant. They were always on hand to explain and reassure and we had complete confidence that they would work constructively and pragmatically with UDG Healthcare to complete the transaction in a way which works for all parties. A big thanks to Martin and the team!”
Client Partner, Martin O’Donoghue commented: “This was a great deal to be a part of and we are delighted to have been able to advise Mike, Bill and Sarah on their sale to UDG. Our ability to draw on our cross disciplinary team from corporate, real estate and employment, alongside our depth of experience advising on similar deals in the healthcare sector, played an important role in securing a successful result for our client. We wish the sellers and the UDG Healthcare team every success for the future”.
The Kerman & Co team was led by corporate partner, Martin O’Donoghue and comprised John Daly (Corporate), Maria Dogaru (Corporate), Jonathan Bruck (Employment) and Jason Hooker (Real Estate).